Dr. Marco Marchesan is an experienced pharmaceutical development professional currently serving as the Head of Product Development at Protina Pharmazeutische GmbH since June 2020. Previously, Dr. Marchesan was the Group Head at Sandoz Development Center/Hexal AG from November 2003 to May 2020, overseeing project management and pharmaceutical development for various dosage forms. Prior roles include Head of Production at Dragenopharm Apotheker Pueschl GmbH and Scientist at Universität Regensburg, with a robust background in managing manufacturing operations and conducting scientific research. Dr. Marchesan holds a Doctorate in Natural Science from the University of Regensburg and a degree in Pharmacy from Università degli Studi di Trieste.
This person is not in the org chart
This person is not in any teams
This person is not in any offices